menu
    • menu

    Company profile for Immuron

    NEW Drugs in Dev: 6
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron’s technology platform is capable of developing and producing an orally stable therapeutic as a potential ‘oral targeted therapy’ for various immune mediated and inflammatory disorders, among them: non-alcoholic steato...
    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron’s technology platform is capable of developing and producing an orally stable therapeutic as a potential ‘oral targeted therapy’ for various immune mediated and inflammatory disorders, among them: non-alcoholic steatohepatitis (NASH) diabetes, colitis, inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), liver fibrosis and other chronic disorders in which the immune system plays a key role in pathogenesis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmuronAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131
    Telephone
    Telephone
    +613 8892 4802
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immuron.com.au/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immuronltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ImmuronLtd?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Emerging Growth Research Raises Immuron Target to $4.00
    Emerging Growth Research Raises Immuron Target to $4.00

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/emerging-growth-research-releases-flash-report-on-immuron-maintains-buy-extended-rating-and-raises

    PHARMIWEB
    22 Apr 2026
    Share Share
    Immuron Double Digit 3Q Sales Growth
    Immuron Double Digit 3Q Sales Growth

    17 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7184439

    FIRSTWORD PHARMA
    17 Apr 2026
    Share Share
    Immuron CEO Steven Lydeamore to Present at Coffee Microcaps
    Immuron CEO Steven Lydeamore to Present at Coffee Microcaps

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3249948/37134/en/Immuron-CEO-Steven-Lydeamore-presentation-at-Coffee-Microcaps-Conference.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Emerging Growth Research Maintains Buy at $3.90 Target
    Emerging Growth Research Maintains Buy at $3.90 Target

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/emerging-growth-research-issues-flash-update-on-immuron-limited-maintains-buy-extended-rating-and

    PHARMIWEB
    05 Mar 2026
    Share Share
    Immuron Reports HY26 Results And Strategic Reset
    Immuron Reports HY26 Results And Strategic Reset

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244392/37134/en/Immuron-Reports-HY26-Results-and-Strategic-Reset.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Immuron Reports Continued Sales Growth
    Immuron Reports Continued Sales Growth

    19 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/19/3220851/37134/en/Immuron-Reports-Continued-Sales-Growth.html

    GLOBENEWSWIRE
    19 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search